Following the combination therapy in the tumor mouse model, the results showed that the number of PD-1+ CD8+, CD8+ granzyme B+, and CD8+ IFN-γ+ T cells significantly increased, and finally, the size and weight of the tumor mass markedly reduced [114]. The gene discussed is GZMB; the disease is neoplasm.